Stocktoria
ACADIA PHARMACEUTICALS INC ACAD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2004-05-27
ACADIA PHARMACEUTICALS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | — | 94.3% | 98.0% | 97.8% |
| Operating margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| Net margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% |
| FCF margin | 9.8% | 16.4% | 2.3% | -22.0% | -26.2% |
| Return on assets | 25.0% | 19.1% | -8.2% | -36.7% | -24.0% |
| Return on equity | 31.9% | 30.9% | -14.2% | -53.9% | -31.0% |
| Current ratio | 3.83 | 2.38 | 2.42 | 4.04 | 6.43 |
| Revenue growth | 11.9% | 31.8% | 40.4% | 6.8% | 9.6% |
Source: SEC EDGAR filings · CIK 0001070494 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.